Drug Profile
Research programme: vesicular monoamine transporter inhibitors - Neurocrine Biosciences
Alternative Names: VMAT2 inhibitors - Neurocrine BiosciencesLatest Information Update: 28 Mar 2021
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action GABA uptake inhibitors; Vesicular monoamine transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bipolar disorders; Movement disorders; Schizophrenia
- Discontinued Epilepsy; Essential tremor; Neuropathic pain
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for research development in Movement-disorders in USA
- 28 Mar 2020 No recent reports of development identified for research development in Bipolar-disorders in USA
- 28 Mar 2020 No recent reports of development identified for research development in Schizophrenia in USA